GAMCO Investors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

GAMCO Investors’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,650	Closed	-$1.37M	–	885
2023 Q2	$1.37M	Buy	+35,650	New	+$915K	0.01%	536

GAMCO Investors's KDNY Position: Q3 2023 in Review

GAMCO Investors sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 35,650 shares — an estimated $1.37M sold.

GAMCO Investors first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $1.37M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

GAMCO Investors reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
GAMCO Investors sold 35,650 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.37M.
GAMCO Investors first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
GAMCO Investors's Chinook Therapeutics, Inc. Common Stock position peaked at $1.37M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on GAMCO Investors's 13F filing for Q3 2023, filed 8 Nov 2023.